Physician

Mueez Ahmed, M.D.

According to 2025 Medicare claims, Mueez Ahmed, M.D. (NPI: 1437171709) practices interventional cardiology in the Warner Robins, GA market, with the plurality of this provider's patient population coming from Houston, GA. This provider's primary affiliated billing organization is CARDIAC CONSULTANTS OF CENTRAL GEORGIA (NPI: 1962779611; TIN: 453852850) and primary practice location at 31093-3624. Ahmed is affiliated with the TC2, LLC (ACO ID: A3365), participating under the MSSP model.

Ahmed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 974 traditional Medicare patients, billed 4,507 HCPCS/CPT codes, and received $303,678 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 3,546 prescription claims across 448 beneficiaries totaling $781,854 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 16 claims. Open Payments data shows 25 records totaling $1,250. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $517,082 to $303,678. In contrast, Part D prescription costs have moved sharply higher in recent years, from $114,421 to $781,854. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $48,315 and ending at $31,522.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,531	6,715	$517,082
2016	1,666	8,265	$602,255
2017	1,767	8,309	$610,855
2018	1,696	7,161	$507,618
2019	1,665	6,494	$514,533
2020	1,334	5,256	$443,664
2021	1,196	4,312	$373,704
2022	1,171	4,054	$360,768
2023	1,111	4,238	$335,019
2024	974	4,507	$303,678

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	312	2,653	$114,421
2016	352	3,220	$172,355
2017	339	3,268	$204,938
2018	341	2,789	$215,538
2019	332	2,657	$251,602
2020	336	2,739	$307,816
2021	352	3,004	$393,969
2022	353	2,742	$389,384
2023	366	2,932	$636,305
2024	448	3,546	$781,854

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$47,663
2016	N/R	15	$26,062
2017	N/R	26	$51,651
2018	11	31	$63,631
2019	N/R	16	$31,472
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	172	326	$89
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	502	514	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	493	899	$85
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	353	533	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	282	321	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	264	12,802	$249,396
Entresto	Sacubitril/Valsartan	174	8,231	$184,429
Xarelto	Rivaroxaban	112	6,647	$119,644
Farxiga	Dapagliflozin Propanediol	128	5,890	$108,702
Brilinta	Ticagrelor	30	1,740	$25,418

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	25	$1,250	ABIOMED
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mueez Ahmed, M.D.?

Tedicare shows public-source Medicare data for Mueez Ahmed, M.D. (NPI 1437171709), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mueez Ahmed, M.D. have ACO affiliation data?

Mueez Ahmed, M.D. is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365).

What billing organization is linked to Mueez Ahmed, M.D.?

Mueez Ahmed, M.D. is linked to CARDIAC CONSULTANTS OF CENTRAL GEORGIA (billing NPI 1962779611) in the available physician profile data.

Does Mueez Ahmed, M.D. have Open Payments data?

Mueez Ahmed, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.